Picture of Biocon logo

BIOCON Biocon Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Biocon, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line8,5597,7166,43012,97814,294
Depreciation
Non-Cash Items2,0636,4238,26010,1484,814
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-6,514-10,177-7,296-9,2754,634
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities11,25912,10418,52529,53940,612
Capital Expenditures-17,463-19,248-17,263-19,316-23,433
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-18,7842,257-125,5559,27121,092
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-36,247-16,991-142,818-10,045-2,341
Financing Cash Flow Items-1,160-1,096-4,856-8,474-23,223
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities25,6402,421130,487-23,327-18,540
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash723-2,4336,411-3,80420,043